Eli Lilly and Company (LLY) vs State Street SPDR S&P 500 ETF Trust (SPY)
See how Eli Lilly and Company and State Street SPDR S&P 500 ETF Trust differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$767.05
NYSEArca
SPDR S&P 500 ETF Trust is an exchange-traded fund that gives investors diversified exposure to large-cap U.S. companies in the S&P 500 Index. It is designed to track or represent a basket of publicly traded securities rather than a single company, making it useful for portfolio allocation, regional exposure, and thematic positioning. Its performance depends on the underlying holdings, sector and country weights, currency movements where relevant, fund expenses, and broader equity-market conditions.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
State Street SPDR S&P 500 ETF TrustSPY
Market Cap$795.307B
Price$767.05
24h Change-0.30%
24h Volume$38.64M
EmployeesN/A
Shares Outstanding1,022,982,116
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
56.5%SPY
43.5%Volume Share
Share of combined 24h volume
LLY
7.3%SPY
92.7%24h Performance
Price change over last 24 hours
LLY
-1.52%SPY
-0.30%Price Comparison
Eli Lilly and Company
State Street SPDR S&P 500 ETF Trust